Beyond Thrombolysis and Thrombectomy: Designing and Conducting Successful Stroke Clinical Trials, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how scientific rationale, patient selection, treatment timing and trial execution can shape stroke clinical development. The featured speaker will discuss cytoprotective therapies, advanced imaging, endpoint selection and the potential role of adaptive and platform trial designs. Attendees will also explore practical considerations for consent, site readiness and recruitment within time-critical stroke care.

TORONTO, Nov. 12, 2026 /PRNewswire/ -- In this free webinar, learn how scientific rationale, patient selection, treatment timing and trial execution can shape stroke clinical development. The featured speaker will discuss cytoprotective therapies, advanced imaging, endpoint selection and the potential role of adaptive and platform trial designs. Attendees will also explore practical considerations for consent, site readiness and recruitment within time-critical stroke care.

Thrombolysis and thrombectomy have transformed acute ischemic stroke care, yet the need for therapies that improve recovery and reduce disability remains. For small and mid-sized biotech companies developing new treatments, a critical challenge is translating a compelling mechanism of action into a trial that can demonstrate meaningful clinical benefit.

This webinar will explore how therapeutic rationale, patient selection, treatment timing and operational execution come together to shape successful stroke clinical development. Cytoprotective therapies offer a potential approach to complement reperfusion, but advancing these candidates requires reproducible evidence across independent laboratories, activity against relevant components of the ischemic cascade and administration within a biologically appropriate window. These considerations provide the foundation for decisions about whom to enroll, when to treat and how to measure benefit.

Building on this foundation, the featured speakers will examine how time from onset, stroke severity and advanced imaging can inform patient selection and treatment timing relative to reperfusion. The discussion will address the balance between identifying patients most likely to benefit while maintaining enrollment feasibility and generalizability. It will also consider how to align endpoints with the expected biological effect and regulatory expectations, including the role of the modified Rankin Scale at 90 days.

Translating these design choices into a feasible study requires flexibility and practical planning. Adaptive and platform designs may support sample-size re-estimation, arm dropping or subgroup enrichment, while preserving trial integrity. Their value depends on execution within the urgency of acute stroke care, supported by appropriate consent procedures, prepared sites, robust staff training, workflow integration and realistic recruitment targets.

By connecting these scientific and operational considerations, this webinar will offer attendees a clearer framework for moving from therapeutic promise to interpretable clinical evidence. The focus will be on designing feasible, scientifically rigorous trials that can demonstrate meaningful improvements in recovery and reduce the lasting burden of stroke.

Register for this webinar to learn how to address scientific, clinical and operational challenges in stroke clinical trials to support more effective trial design and execution.

Join Thomas Devlin, MD, PhD, Professor of Neurology, Morehouse School of Medicine, Director, CommonSpirit Memorial Neuroscience Institute; Julie Krop, MD, Chief Medical Officer, DiaMedica Therapeutics; and Roberta Anderson, PhD, ACE Therapeutic Strategy Head, Neuroscience, Allucent, for the live webinar on Wednesday, December 2, 2026, at 11am EST (5pm CET / EU-Central).

For more information, or to register for this event, visit Beyond Thrombolysis and Thrombectomy: Designing and Conducting Successful Stroke Clinical Trials.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks